Inhibitors in haemophilia A: the role of VWF/FVIII concentrates--a meeting report.
Kaveri
S
S
Institut National de la Santé et de la Recherche Médicale (INSERM), U872, Centre de Recherche des Cordeliers, Paris, France. srini.kaveri@crc.jussieu.fr
Gringeri
A
A
Heisel-Kurth
M
M
Kreuz
W
W
D019774:Blood Coagulation Factor Inhibitors / Q000276:immunology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D008297:Male; D014841:von Willebrand Factor / Q000276:immunology / Q000627:therapeutic use*
D019774:Blood Coagulation Factor Inhibitors; D014841:von Willebrand Factor; D005169:Factor VIII